Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shentong Granules Plus Prednisone for Severe IgA Nephropathy
NCT02712697Unknown
- Sponsor
- Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Shentong Granules in IgA nephropathy (IgAN) (2 arms), sponsored by Shanghai University of Traditional Chinese Medicine. Primary endpoint: Glomerular filtration rate at 48 weeks. Status: unknown.
02
Drugs
Shentong Granules
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT02712697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02712697.